切片設備的全球市場的預測(～2030年)

全球切片設備的市場規模，調查期間中將以年複合成長率6.80％健全的成長。

本報告提供全球切片設備市場相關調查分析，提供市場動態，地區和市場區隔的分析，企業簡介等資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 市場動態

• 促進因素
• 阻礙因素
• 機會
• 課題
• 宏觀經濟指標

第4章 市場要素的分析

• 波特的五力分析

第5章 全球切片設備市場:各產品類型

• 簡介
  • 切片檢查槍
  • 切片檢查指南系統
  • 切片穿刺針
  • 切片鉗
  • 其他

第6章 全球切片設備市場:各用途

• 簡介
  • 手術切片檢查
  • 皮膚切片檢查
  • 針切片檢查
  • 骨髓切片檢查
  • 癌症診斷
  • 其他

第7章 全球切片設備市場:各終端用戶

• 簡介
  • 醫院
  • 專門診療所
  • 診斷中心
  • 學術·研究機關
  • 其他

第8章 全球切片設備市場:各地區

• 簡介
  • 美國
  • 歐洲
  • 亞太地區
  • 中東·非洲

第9章 企業形勢

• 簡介

第10章 企業簡介

• ARGON MEDICAL DEVICES, INC.
• BD
• COOK MEDICAL
• C. R. BARD, INC.
• CREGANNA
• FOCAL THERAPEUTICS, INC.
• HOLOGIC, INC.
• INTEGRA LIFESCIENCES CORPORATION
• LEICA BIOSYSTEMS
• PRECISION BIOPSY, LLC
• SCION MEDICAL TECHNOLOGIES, LLC.
• 其他

第11章 附錄

Biopsy Devises Market Forecast to 2030

Market Overview

Biopsy Devises Market is projected to register a healthy CAGR of 6.80% during the review period. The rising predominance of disease and expanding inclination for insignificantly obtrusive medical procedures are driving the market development.

A biopsy is a sort of demonstrative system used to track down both dangerous and non-destructive irregularities in the human body. The worldwide market for biopsy gadgets is projected to grow because of the rising occurrence of disease in the populace. For example, malignant growth is the second-driving reason for death in the US after coronary illness and is the essential driver of death in Canada. As per the American Disease Society, there were 693,000 malignant growth fatalities and 1.9 million new disease analyze in 2018. In North America, prostate malignant growth is the sickness that is most often analyzed in men, yet bosom disease keeps on being the most well-known disease in ladies. Cellular breakdown in the lungs keeps on being the main source of death in the two genders. One of the primary drivers of the populace's malignant growth frequencies rising is the quick change in way of life, as well as the admission of liquor and cigarette items.

Market Segmentation

Based on the type of product, the Biopsy Devices Market is segmented into biopsy guns, biopsy guiding systems, biopsy needles, biopsy forceps, localization wires, and others.

The global market for biopsy devices has been divided into submarkets for breast, prostate, liver, lung, gynecological, and other applications.

The global market for biopsy devices has been divided into several subsectors based on the method used for guidance, including stereotactic, MRI, CT, and ultrasound.

The global industry for biopsy equipment has been divided into hospitals and clinics, diagnostic and imaging centers, academic and research institutes, and others based on end-user.

Regional Analysis

The development of the North America Biopsy Gadgets market is credited to the high market entrance paces of state-of-the-art items, like vacuum-helped biopsy frameworks, and a rapidly rising market interest for expendable items.

North America Biopsy Gadgets market represents the biggest market share because of the presence of deep-rooted market players in the country, high market entrance paces of state-of-the-art items, like vacuum-helped biopsy frameworks, and a rapidly rising market interest for expendable items. The tendency for negligibly obtrusive techniques, an expansion in disease frequency universally, and government drives for conclusion in this region are the main impetuses behind the development of the biopsy instruments market.

The Asia-Pacific Biopsy Gadgets Market is supposed to develop at the most noteworthy rate from 2018 to 2030. This is because of the rising frequency of disease, the huge populaces in countries like China and India, the better medical services framework, expanded medical care spending and government drives, and the rising consideration of significant market members in the region are adding to the section's ascent.

Major Players

Argon Medical Devices (US), BD (US), Cook Medical (US), CONMED Corporation (US), Olympus Corporation (Japan), Hologic, Inc. (US), Cardinal Health Inc. (US), Integra LifeSciences (US), Medtronic plc (US), Mammotome (US), INRAD (US), and Trivitron Healthcare (India) are the major companies in the market.

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 DEFINITION
• 1.2 SCOPE OF STUDY
• 1.3 RESEARCH OBJECTIVE
• 1.4 ASSUMPTIONS & LIMITATIONS
• 1.5 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH PROCESS
• 2.2 PRIMARY RESEARCH
• 2.3 SECONDARY RESEARCH

3 MARKET DYNAMICS

• 3.1 DRIVERS
• 3.2 RESTRAINTS
• 3.3 OPPORTUNITIES
• 3.4 CHALLENGES
• 3.5 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

• 4.1 PORTER'S FIVE FORCES MODEL
  • 4.1.1 BARGAINING POWER OF SUPPLIERS
  • 4.1.2 BARGAINING POWER OF CUSTOMER
  • 4.1.3 INTENSITY OF COMPETITOR'S
  • 4.1.4 THREAT OF NEW ENTRANTS

5 GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT TYPE

• 5.1 INTRODUCTION
  • 5.1.1 BIOPSY GUNS
  • 5.1.2 BIOPSY GUIDANCE SYSTEM
  • 5.1.3 BIOPSY NEEDLES
  • 5.1.4 BIOPSY FORCEPS
  • 5.1.5 OTHERS

6 GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION

• 6.1 INTRODUCTION
  • 6.1.1 SURGICAL BIOPSY
  • 6.1.2 SKIN BIOPSY
  • 6.1.3 NEEDLE BIOPSY
  • 6.1.4 BONE MARROW BIOPSY
  • 6.1.5 CANCER DIAGNOSIS
  • 6.1.6 OTHERS

7 GLOBAL BIOPSY DEVICES MARKET, BY END USER

• 7.1 INTRODUCTION
  • 7.1.1 HOSPITALS
  • 7.1.3 SPECIALTY CLINICS
  • 7.1.4 DIAGNOSTIC CENTERS ACADEMIC & RESEARCH INSTITUTES
  • 7.1.5 ACADEMIC & RESEARCH INSTITUTES
  • 7.1.6 OTHERS

8 GLOBAL BIOPSY DEVICES MARKET, BY REGIONS

• 8.1 INTRODUCTION
  • 8.1.1 AMERICAS
    • 8.1.1.1 NORTH AMERICA
    • 8.1.1.2 SOUTH AMERICA
  • 8.1.2 EUROPE
    • 8.1.2.1 GERMANY
    • 8.1.2.2 FRANCE
    • 8.1.2.3 UK
    • 8.1.2.4 ITALY
    • 8.1.2.5 SPAIN
    • 8.1.2.6 REST OF EUROPE
  • 8.1.3 ASIA PACIFIC
    • 8.1.3.1 JAPAN
    • 8.1.3.2 CHINA
    • 8.1.3.3 INDIA
    • 8.1.3.4 REPUBLIC OF KOREA
    • 8.1.3.5 REST OF ASIA PACIFIC
  • 8.1.4 MIDDLE EAST & AFRICA

9 COMPANY LANDSCAPE

• 9.1 INTRODUCTION
  • 9.1.1 MERGERS ACQUISITIONS
  • 9.1.2 COLLABORATIONS
  • 9.1.3 RELEASE/NEW PRODUCT LAUNCHES
  • 9.1.4 OTHER (EXPANSION, UPDATES, PARTNERSHIP)

10 COMPANY PROFILE

• 10.1 ARGON MEDICAL DEVICES, INC.
  • 10.1.1 COMPANY OVERVIEW
  • 10.1.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
  • 10.1.3 FINANCIALS
  • 10.1.4 KEY DEVELOPMENTS
  • 10.1.5 SWOT ANALYSIS
• 10.2 BD
  • 10.2.1 OVERVIEW
  • 10.2.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
  • 10.2.3 FINANCIALS
  • 10.2.4 KEY DEVELOPMENTS
  • 10.2.5 SWOT ANALYSIS
• 10.3 COOK MEDICAL
  • 10.3.1 OVERVIEW
  • 10.3.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
  • 10.3.3 FINANCIALS
  • 10.3.4 KEY DEVELOPMENTS
  • 10.3.5 SWOT ANALYSIS
• 10.4 C. R. BARD, INC.
  • 10.4.1 OVERVIEW
  • 10.4.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
  • 10.4.3 FINANCIALS
  • 10.4.4 KEY DEVELOPMENTS
  • 10.4.5 SWOT ANALYSIS
• 10.5 CREGANNA
  • 10.5.1 OVERVIEW
  • 10.5.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
  • 10.5.3 FINANCIALS
  • 10.5.4 KEY DEVELOPMENTS
  • 10.5.5 SWOT ANALYSIS
• 10.6 FOCAL THERAPEUTICS, INC.
  • 10.6.1 OVERVIEW
  • 10.6.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
  • 10.6.3 FINANCIALS
  • 10.6.4 KEY DEVELOPMENTS
  • 10.6.5 SWOT ANALYSIS
• 10.7 HOLOGIC, INC.
  • 10.7.1 OVERVIEW
  • 10.7.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
  • 10.7.3 FINANCIALS
  • 10.7.4 KEY DEVELOPMENTS
  • 10.7.5 SWOT ANALYSIS
• 10.8 INTEGRA LIFESCIENCES CORPORATION
  • 10.8.1 OVERVIEW
  • 10.8.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
  • 10.8.3 FINANCIALS
  • 10.8.4 KEY DEVELOPMENTS
  • 10.8.5 SWOT ANALYSIS
• 10.9 LEICA BIOSYSTEMS
  • 10.9.1 OVERVIEW
  • 10.9.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
  • 10.9.3 FINANCIALS
  • 10.9.4 KEY DEVELOPMENTS
  • 10.9.5 SWOT ANALYSIS
• 10.10 PRECISION BIOPSY, LLC
  • 10.10.1 OVERVIEW
  • 10.10.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
  • 10.10.3 FINANCIALS
  • 10.10.4 KEY DEVELOPMENTS
  • 10.10.5 SWOT ANALYSIS
• 10.11 SCION MEDICAL TECHNOLOGIES, LLC.
  • 10.11.1 OVERVIEW
  • 10.11.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
  • 10.11.3 FINANCIALS
  • 10.11.4 KEY DEVELOPMENTS
  • 10.11.5 SWOT ANALYSIS
• 10.12 OTHERS

11 APPENDIX

LIST OF TABLES

• TABLE 1 GLOBAL BIOPSY DEVICES MARKET, 2020-2027 (USD MILLION)
• TABLE 2 GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)
• TABLE 3 GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
• TABLE 4 GLOBAL BIOPSY DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
• TABLE 5 GLOBAL BIOPSY DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION)

LIST OF FIGURES

• FIGURE 1 RESEARCH PROCESS
• FIGURE 2 PORTERS FIVE FORCES MODEL
• FIGURE 3 GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT TYPE
• FIGURE 4 GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION
• FIGURE 5 GLOBAL BIOPSY DEVICES MARKET, BY END USER
• FIGURE 6 GLOBAL BIOPSY DEVICES MARKET, BY REGION
• FIGURE 7 GLOBAL BIOPSY DEVICES MARKET: COMPANY SHARE ANALYSIS, 2020 (%)